FIELD: biotechnology; chemistry.
SUBSTANCE: invention relates to biochemistry, particularly to a method of isolating a subgroup of antibodies. Also disclosed is a pharmaceutical composition containing said antibody.
EFFECT: invention enables to efficiently obtain a subgroup of antibodies.
3 cl, 8 ex, 4 tbl, 18 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODIES TO INTERLEUKIN-31 FOR VETERINARY USE | 2019 |
|
RU2795411C2 |
| STABLE MULTI-SPECIFIC ANTIBODIES | 2018 |
|
RU2779602C2 |
| BISPECIFIC ANTIBODIES | 2020 |
|
RU2818588C2 |
| ADAM9-BINDING MOLECULES AND THEIR APPLICATION METHODS | 2017 |
|
RU2783619C2 |
| ANTI-PD-1 ANTIBODIES | 2019 |
|
RU2788095C2 |
| METHOD FOR OBTAINING BI-SPECIFIC ANTIBODIES, BI-SPECIFIC ANTIBODIES AND THERAPEUTIC APPLICATION OF SUCH ANTIBODIES | 2018 |
|
RU2795240C2 |
| PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
| TUMOR-TARGETED AGONISTIC CD28-ANTIGEN-BINDING MOLECULES | 2019 |
|
RU2808030C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES CONTAINING ANTI-FAP CLONE 212 | 2019 |
|
RU2799429C2 |
| MOLECULES BINDING WITH CD38 AND PD-L1 | 2017 |
|
RU2764201C2 |
